Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Medical marijuana use might increase the incidence and severity of cannabis use disorder

Staff Writer
Staff Writer 2 years ago
Updated 2022/03/19 at 1:28 AM
Share
SHARE

Although the use of medicinal marijuana may alleviate symptoms of chronic pain and affective disorders, it could also result in the onset of cannabis use disorder (CUD), according to new research in JAMA.

As part of a randomized clinical trial of 186 participants, the research was conducted between July 2017 and July 2020 in the Greater Boston area.

“Participants were adults aged 18 to 65 years with a chief concern of pain, insomnia, or anxiety or depressive symptoms,” the JAMA report states.

“Participants were randomized 2:1 to either the immediate card acquisition group or the delayed card acquisition group. Randomization was stratified by chief concern, age, and sex.”

The group of participants known as the immediate card acquisition group that obtained a medical marijuana card immediately after randomization were more likely to report more cannabis use disorder symptoms.

“This randomized clinical trial found that immediate acquisition of a medical marijuana card led to a higher incidence and severity of CUD; resulted in no significant improvement in pain, anxiety, or depressive symptoms; and improved self-rating of insomnia symptoms,” the study’s authors revealed.

“Further investigation of the benefits of medical marijuana card ownership for insomnia and the risk of CUD are needed, particularly for individuals with anxiety or depressive symptoms.”

You Might Also Like

Study boasts MDMA-assisted therapy for PTSD patients

How the brain is organized is revealed by the largest genetic study of brain structure to date

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

New study reveals positive results from postpartum depression treatment Zuranolone

New study explores magic mushrooms for anorexia nervosa psychopathology

TAGGED: cannabis use disorder, marijuana
Staff Writer March 18, 2022
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Research uncovers brain differences in young children with binge eating disorder
Next Article How skin biopsy may result in early identification and diagnosis of Parkinson’s disease

Recommended

Clinical

Study boasts MDMA-assisted therapy for PTSD patients

1 Min Read
Clinical

How the brain is organized is revealed by the largest genetic study of brain structure to date

2 Min Read
Clinical

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

3 Min Read
Clinical

New study reveals positive results from postpartum depression treatment Zuranolone

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?